02 March 1998
Late expession of the HLA-DR and HLA-ABC antigens in the posttransplanted myocardium as evidence of chronic rejection
Romuald Wojnicz, Marian Zembala, Michał Zakliczyński, Jerzy Nożyński, Jerzy Foremny, Jacek Wojarski, Danuta Muszko, M. Marius RozekMed Sci Monit 1998; 4(2): CR263-267 :: ID: 502598
Abstract
The up-regulation of human leukocyte antigens (HLA) class I and class II, has been suspected of involvement in chronic rejections following orthotopic heart transplantations (OHT). A total of forty four endomyocardial biopsy specimens from 11 patients were immunohistochemically analyzed at intervals of 7±2, 30±4, 84±10 and 340±40 days following OHT. The immunohistological study was based on cryostat sections using monoclonal mouse anti-human HLA antibodies. To detect bounding primary antibodies, the DAKO LSAB¨+ Kit/Alkaline Phosphatase detection system was used. For the assessment of the intensity of staining, a semiquantitative scale of 0-3 was employed. HLA class I (ABC) and class II (DR) staining ³2+ was clinically significant. The study group consisted of patients with ischemic cardiomyopathy (six patients) and dilated cardiomyopathy (five patients) as an indication for OHT. The mean donor ischemia time was 116 minutes (ranging between 45 and 194). None of the patients died during the 14 months observation period. Histological rejection(³2) during the time of the immunohistological study was seen in 2 cases at 7±2 days, in 5 cases at 30±4 days, in 3 cases at 84±10 days and in 1 patient at 340±40 days following OHT. In all endomyocardial biopsies, a late expression (300 days post OHT) of HLA-ABC and HLA-DR occurred as moderate (1/11) and severe (10/11). A significant expression of HLA was only seen in one patient at 7± days following OHT, (7±, vs 300±, p=0.005). This expression had a strong diffuse character and was associated with histological signs of an acute injury. Generally, in contrast to focal and vascular staining during the early period, late staining was diffuse in distribution, including sarcolemmic myocyte staining without histologic signs of myocyte injury. In addition, HLA-DR staining was more intense in capillary endothelial cells as opposed to HLA-ABC, which predominated on myocytes. Late up-regulation of HLA in the myocardium may reflect the time-dependent chronic rejection, without histological signs of a myocardial injury. Our results confirm the hypothesis that the microvascular expression of HLA during an acute rejection may differ from that seen in the chronic state.
Keywords: orthotopic heart transplantation, immunohistology, HLA molecules
Editorial
01 March 2025 : Editorial
Editorial: The World Health Organization (WHO) Updated List of Emerging and Potentially Pandemic Pathogens Includes Yersinia pestis as Plague Vaccines Await Clinical TrialsDOI: 10.12659/MSM.948672
Med Sci Monit 2025; 31:e948672
In Press
Clinical Research
Exploring the Association Between Serum Neurogranin, Nardilysin, and Ischemic Stroke: A Case-Control Study ...Med Sci Monit In Press; DOI: 10.12659/MSM.947703
Clinical Research
Comparative Analysis of Laser Therapies for Striae Distensae: Fractional CO₂ vs Combined Q-Switch Nd:YAGMed Sci Monit In Press; DOI: 10.12659/MSM.947464
Database Analysis
Utility of Central Venous Oxygen Saturation Gradient in Predicting Mortality in Dialysis with Catheter AccessMed Sci Monit In Press; DOI: 10.12659/MSM.947298
Clinical Research
Intraoperative Renal Near-Infrared Spectroscopy Monitoring as a Predictor of Renal Outcomes in Cardiac SurgeryMed Sci Monit In Press; DOI: 10.12659/MSM.947462
Most Viewed Current Articles
17 Jan 2024 : Review article 7,094,149
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 702,321
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 27,595
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 21,787
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912